143 related articles for article (PubMed ID: 16216419)
1. Hepatocellular carcinoma as a complex polygenic disease. Interpretive analysis of recent developments on genetic predisposition.
Feo F; De Miglio MR; Simile MM; Muroni MR; Calvisi DF; Frau M; Pascale RM
Biochim Biophys Acta; 2006 Apr; 1765(2):126-47. PubMed ID: 16216419
[TBL] [Abstract][Full Text] [Related]
2. Role of HSP90, CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer.
Pascale RM; Simile MM; Calvisi DF; Frau M; Muroni MR; Seddaiu MA; Daino L; Muntoni MD; De Miglio MR; Thorgeirsson SS; Feo F
Hepatology; 2005 Dec; 42(6):1310-9. PubMed ID: 16317707
[TBL] [Abstract][Full Text] [Related]
3. Polygenic control of hepatocarcinogenesis in Copenhagen x F344 rats.
De Miglio MR; Pascale RM; Simile MM; Muroni MR; Virdis P; Kwong KM; Wong LK; Bosinco GM; Pulina FR; Calvisi DF; Frau M; Wood GA; Archer MC; Feo F
Int J Cancer; 2004 Aug; 111(1):9-16. PubMed ID: 15185337
[TBL] [Abstract][Full Text] [Related]
4. Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease.
Calvisi DF; Pinna F; Ladu S; Pellegrino R; Muroni MR; Simile MM; Frau M; Tomasi ML; De Miglio MR; Seddaiu MA; Daino L; Sanna V; Feo F; Pascale RM
Carcinogenesis; 2008 Aug; 29(8):1639-47. PubMed ID: 18579559
[TBL] [Abstract][Full Text] [Related]
5. Genetic and epigenetic control of molecular alterations in hepatocellular carcinoma.
Feo F; Frau M; Tomasi ML; Brozzetti S; Pascale RM
Exp Biol Med (Maywood); 2009 Jul; 234(7):726-36. PubMed ID: 19429855
[TBL] [Abstract][Full Text] [Related]
6. Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC.
Calvisi DF; Pinna F; Ladu S; Pellegrino R; Simile MM; Frau M; De Miglio MR; Tomasi ML; Sanna V; Muroni MR; Feo F; Pascale RM
Gut; 2009 May; 58(5):679-87. PubMed ID: 19136513
[TBL] [Abstract][Full Text] [Related]
7. Interaction of major genes predisposing to hepatocellular carcinoma with genes encoding signal transduction pathways influences tumor phenotype and prognosis.
Feo F; Frau M; Pascale RM
World J Gastroenterol; 2008 Nov; 14(43):6601-15. PubMed ID: 19034960
[TBL] [Abstract][Full Text] [Related]
8. Frequent loss of heterozygosity at the Hcr1 (hepatocarcinogenesis resistance) locus on chromosome 10 in primary hepatocellular carcinomas from LFF1 rat strain.
De Miglio MR; Muroni MR; Simile MM; Virdis P; Asara G; Frau M; Calvisi DF; Seddaiu MA; Pascale RM; Feo F
Hepatology; 2001 May; 33(5):1110-7. PubMed ID: 11343238
[TBL] [Abstract][Full Text] [Related]
9. Chromosome mapping of multiple loci affecting the genetic predisposition to rat liver carcinogenesis.
De Miglio MR; Pascale RM; Simile MM; Muroni MR; Calvisi DF; Virdis P; Bosinco GM; Frau M; Seddaiu MA; Ladu S; Feo F
Cancer Res; 2002 Aug; 62(15):4459-63. PubMed ID: 12154055
[TBL] [Abstract][Full Text] [Related]
10. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
11. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
12. Dissection of signal transduction pathways as a tool for the development of targeted therapies of hepatocellular carcinoma.
Calvisi DF; Pascale RM; Feo F
Rev Recent Clin Trials; 2007 Sep; 2(3):217-36. PubMed ID: 18474008
[TBL] [Abstract][Full Text] [Related]
13. Alteration of the p14(ARF) gene and p53 status in human hepatocellular carcinomas.
Ito T; Nishida N; Fukuda Y; Nishimura T; Komeda T; Nakao K
J Gastroenterol; 2004; 39(4):355-61. PubMed ID: 15168247
[TBL] [Abstract][Full Text] [Related]
14. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
15. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
Xue KX
Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
[TBL] [Abstract][Full Text] [Related]
16. Experimental Models to Define the Genetic Predisposition to Liver Cancer.
Pascale RM; Simile MM; Peitta G; Seddaiu MA; Feo F; Calvisi DF
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31569678
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice.
Katzenellenbogen M; Mizrahi L; Pappo O; Klopstock N; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Domany E; Galun E; Goldenberg D
Mol Cancer Res; 2007 Nov; 5(11):1159-70. PubMed ID: 18025261
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis.
Pascale RM; Simile MM; De Miglio MR; Muroni MR; Calvisi DF; Asara G; Casabona D; Frau M; Seddaiu MA; Feo F
Hepatology; 2002 Jun; 35(6):1341-50. PubMed ID: 12029619
[TBL] [Abstract][Full Text] [Related]
19. Analysis of loss of heterozygosity in neoplastic nodules induced by diethylnitrosamine in the resistant BFF1 rat strain.
Gariboldi M; Pascale R; Manenti G; De Miglio MR; Calvisi D; Carru A; Dragani TA; Feo F
Carcinogenesis; 1999 Jul; 20(7):1363-8. PubMed ID: 10383913
[TBL] [Abstract][Full Text] [Related]
20. Review of genetic and epigenetic alterations in hepatocarcinogenesis.
Herath NI; Leggett BA; MacDonald GA
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):15-21. PubMed ID: 16706806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]